SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3

Detalles Bibliográficos
Autores principales: Falsey, Ann R., Frenck, Robert W., Walsh, Edward E., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Bailey, Ruth, Swanson, Kena A., Xu, Xia, Koury, Kenneth, Kalina, Warren, Cooper, David, Zou, Jing, Xie, Xuping, Xia, Hongjie, Türeci, Özlem, Lagkadinou, Eleni, Tompkins, Kristin R., Shi, Pei-Yong, Jansen, Kathrin U., Şahin, Uğur, Dormitzer, Philip R., Gruber, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461567/
https://www.ncbi.nlm.nih.gov/pubmed/34525276
http://dx.doi.org/10.1056/NEJMc2113468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461567/
https://www.ncbi.nlm.nih.gov/pubmed/34525276
http://dx.doi.org/10.1056/NEJMc2113468

Ejemplares similares